{
    "2020-01-28": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Why Earnings Season Could Be Great for Novartis (NVS)",
                "features": {
                    "keywords": [
                        "Earnings Season",
                        "Great",
                        "Novartis"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258 (Revised)",
                "features": {
                    "keywords": [
                        "Jazz",
                        "Submits",
                        "NDA",
                        "Xyrem",
                        "Follow-On",
                        "Candidate",
                        "JZP-258"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}